“Aaron is a friendly, thoughtful, committed and dynamic recruitment who understands the needs of both clients and companies and makes the whole process painless and professional. Aaron is an excellent communicator and never went silent on me. In fact, he even was in communication multiple times during his holiday. I highly recommend reaching out to him if you are looking to hire or trying to find a suitable opening for your next role. He truly understands multiple industries and excels in the CDMO markets.”

Senior Director of Business Development, Zhejiang Jiuzhou Pharmaceutical

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (Jiuzhou Pharma) is a publicly listed company in China, focusing on the research/development and production of APIs/intermediates, providing products and CRO/CMO services to the customers. Adhering to the principle of “Live on high quality”, Jiuzhou Pharma has established an efficient quality control system, and has acquired certifications for ISO9001, ISO14001 and GMP. Management of the company is conducted in the light of the GMP criterion, so as to effectively control the process and quality of raw materials, intermediates and finished products. APIs such as Carbamazepine, Ketoprofen etc. have passed GMP inspections and obtained COS certificates.

Zhejiang Raybow Pharmaceutical Co. Ltd. is the CDMO division of Jiuzhou Pharma, focused on API development and manufacturing, which is located in the Linhai county, Taizhou City, Zhejiang province of China. The state of the art manufacturing facility has R&D centre, scale up plant and GMP production workshops. Raybow is a world leader in the development and manufacturing of Carbamazepine APIs capturing 40% international market.

Company website – https://en.jiuzhoupharma.com/ 

​To find out more about Zhejiang Jiuzhou Pharmaceutical, contact Aaron Dudley on +44 (0)20 3854 7700 or aaron.dudley@mantellassociates.com.